Cargando…
Novel approaches for treating hypertension
Hypertension, or high blood pressure, is a prevalent yet modifiable risk factor for cardiovascular disease. While there are many effective treatments available to combat hypertension, patients often require at least two to three medications to control blood pressure, although there are patients who...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000Research
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288674/ https://www.ncbi.nlm.nih.gov/pubmed/28184289 http://dx.doi.org/10.12688/f1000research.10117.1 |
_version_ | 1782504372493615104 |
---|---|
author | Freeman, Andrew J. Vinh, Antony Widdop, Robert E. |
author_facet | Freeman, Andrew J. Vinh, Antony Widdop, Robert E. |
author_sort | Freeman, Andrew J. |
collection | PubMed |
description | Hypertension, or high blood pressure, is a prevalent yet modifiable risk factor for cardiovascular disease. While there are many effective treatments available to combat hypertension, patients often require at least two to three medications to control blood pressure, although there are patients who are resistant to such therapies. This short review will briefly update on recent clinical advances and potential emerging therapies and is intended for a cross-disciplinary readership. |
format | Online Article Text |
id | pubmed-5288674 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | F1000Research |
record_format | MEDLINE/PubMed |
spelling | pubmed-52886742017-02-08 Novel approaches for treating hypertension Freeman, Andrew J. Vinh, Antony Widdop, Robert E. F1000Res Review Hypertension, or high blood pressure, is a prevalent yet modifiable risk factor for cardiovascular disease. While there are many effective treatments available to combat hypertension, patients often require at least two to three medications to control blood pressure, although there are patients who are resistant to such therapies. This short review will briefly update on recent clinical advances and potential emerging therapies and is intended for a cross-disciplinary readership. F1000Research 2017-01-27 /pmc/articles/PMC5288674/ /pubmed/28184289 http://dx.doi.org/10.12688/f1000research.10117.1 Text en Copyright: © 2017 Freeman AJ et al. http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Freeman, Andrew J. Vinh, Antony Widdop, Robert E. Novel approaches for treating hypertension |
title | Novel approaches for treating hypertension |
title_full | Novel approaches for treating hypertension |
title_fullStr | Novel approaches for treating hypertension |
title_full_unstemmed | Novel approaches for treating hypertension |
title_short | Novel approaches for treating hypertension |
title_sort | novel approaches for treating hypertension |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5288674/ https://www.ncbi.nlm.nih.gov/pubmed/28184289 http://dx.doi.org/10.12688/f1000research.10117.1 |
work_keys_str_mv | AT freemanandrewj novelapproachesfortreatinghypertension AT vinhantony novelapproachesfortreatinghypertension AT widdoproberte novelapproachesfortreatinghypertension |